Cosmo Pharmaceuticals Competitors and Similar CompaniesClear all
Cosmo Pharmaceuticals's competitors and similar companies include TRB Chemedica, PhaseBio Pharmaceuticals, Nomax and JETEMA.
 Cosmo Pharmaceuticals Cosmo Pharmaceuticals is a company that focuses on solutions in the areas of astroenterology and endoscopy. |  TRB Chemedica TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices. |  PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. |  Nomax Nomax is a specialty pharmaceutical company focused on developing niche pharmaceutical products for patients and other pharmaceutical companies. |  JETEMA JETEMA (제테마, formerly known as Pronexx) is a company that specializes in the research and development of medicines and medical devices. | |
Founding Date | Founding Date 1997 | Founding Date 1980 | Founding Date 2002 | Founding Date 1982 | Founding Date 2009 |
Type | Type Public | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Dublin, IE HQ | Locations Genève, CH HQ Buenos Aires, AR Biedermannsdorf, AT Campinas, BR Archamps, FR Feldkirchen, DE Sai Ying Pun, HK see more | Locations Malvern, US HQ | Locations HQ | Locations Weonju, KR HQ Yongin Si, KR Rayong, TH |
Employees | Employees 339 | Employees 900 | Employees 22 | Employees N/A | Employees 227 |
Financial | |||||
Revenue (est.) | Revenue (est.) €92.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $10.8m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) ₩58.7b (FY, 2023) |
Cost of goods | Cost of goods €21.8m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ₩23.8b (FY, 2023) |
Gross profit | Gross profit €72.5m (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ₩36.4b (FY, 2023) |
Net income | Net income (€4.7m) (FY, 2023) | Net income N/A | Net income ($131.1m) (FY, 2021) | Net income N/A | Net income ₩13.6b (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
TRB Chemedica
HQ
Genève, CH
Employees
900
TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices.
View companyPhaseBio Pharmaceuticals
HQ
Malvern, US
Employees
22
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
View companyNomax
HQ
Nomax is a specialty pharmaceutical company focused on developing niche pharmaceutical products for patients and other pharmaceutical companies.
View companyJETEMA
HQ
Weonju, KR
Employees
227
JETEMA (제테마, formerly known as Pronexx) is a company that specializes in the research and development of medicines and medical devices.
View company